<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>10x Genomics Inc — News on 6ix</title>
<link>https://6ix.com/company/10x-genomics-inc</link>
<description>Latest news and press releases for 10x Genomics Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Sun, 19 Apr 2026 02:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/10x-genomics-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835cf4e78dffbe2df11ecda.webp</url>
<title>10x Genomics Inc</title>
<link>https://6ix.com/company/10x-genomics-inc</link>
</image>
<item>
<title>10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-introduces-atera-a-new-platform-to-redefine-how-biology-is-measured-and-understood</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-introduces-atera-a-new-platform-to-redefine-how-biology-is-measured-and-understood</guid>
<pubDate>Sun, 19 Apr 2026 02:00:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented scale.</description>
</item>
<item>
<title>10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-to-report-first-quarter-2026-financial-results-on-may-7-2026</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-to-report-first-quarter-2026-financial-results-on-may-7-2026</guid>
<pubDate>Wed, 15 Apr 2026 20:05:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended March 31, 2026 after market close on Thursday, May 7, 2026. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company</description>
</item>
<item>
<title>Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs</title>
<link>https://6ix.com/company/10x-genomics-inc/news/bioptimus-announces-stela-the-worlds-largest-clinically-linked-spatial-biology-atlas-alongside-key-partners-10x-genomics-and-broad-clinical-labs</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/bioptimus-announces-stela-the-worlds-largest-clinically-linked-spatial-biology-atlas-alongside-key-partners-10x-genomics-and-broad-clinical-labs</guid>
<pubDate>Wed, 25 Mar 2026 11:00:00 GMT</pubDate>
<description>Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative anchored by a partnership with 10x Genomics, Inc. (Nasdaq: TXG) and Broad Clinical Labs.</description>
</item>
<item>
<title>10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-to-participate-in-the-46th-annual-td-cowen-health-care-conference</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-to-participate-in-the-46th-annual-td-cowen-health-care-conference</guid>
<pubDate>Thu, 19 Feb 2026 21:05:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, at 11:50 a.m. Eastern Time.</description>
</item>
<item>
<title>10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-reports-fourth-quarter-210500962</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-reports-fourth-quarter-210500962</guid>
<pubDate>Thu, 12 Feb 2026 21:05:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided its outlook for 2026.</description>
</item>
<item>
<title>PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology</title>
<link>https://6ix.com/company/10x-genomics-inc/news/pharosai-and-10x-genomics-partner-to-transform-cancer-research-with-ai-and-spatial-biology</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/pharosai-and-10x-genomics-partner-to-transform-cancer-research-with-ai-and-spatial-biology</guid>
<pubDate>Wed, 04 Feb 2026 05:00:00 GMT</pubDate>
<description>Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine</description>
</item>
<item>
<title>10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-report-fourth-quarter-210500767</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-report-fourth-quarter-210500767</guid>
<pubDate>Thu, 22 Jan 2026 21:05:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Thursday, February 12, 2026. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be acc</description>
</item>
<item>
<title>10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-launches-study-advance-141100923</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-launches-study-advance-141100923</guid>
<pubDate>Mon, 12 Jan 2026 14:11:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral blood samples from patients living with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and giant cell arteritis (GCA) to uncover immune signatures associated with disease activity, flare, remission and therapeutic response.</description>
</item>
<item>
<title>10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-advance-research-diagnostic-141000261</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-advance-research-diagnostic-141000261</guid>
<pubDate>Mon, 12 Jan 2026 14:10:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to analyze tumor samples from patients with major solid cancer types to uncover biological features associated with treatment response, resistance and disease progression. The company also announced plans to establish a CLIA-certified laboratory. Together, these efforts mark the beginning of a multi-year research initiative to incorporate single cell an</description>
</item>
<item>
<title>Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology</title>
<link>https://6ix.com/company/10x-genomics-inc/news/cancer-research-institute-launches-transformative-ai-driven-immuno-oncology-initiative-powered-by-10x-genomics-technology</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/cancer-research-institute-launches-transformative-ai-driven-immuno-oncology-initiative-powered-by-10x-genomics-technology</guid>
<pubDate>Mon, 12 Jan 2026 14:00:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with the Cancer Research Institute (CRI) to advance the frontiers of immuno-oncology through high-resolution molecular data and AI. The multi-phase project will combine 10x's Chromium single cell and Xenium spatial platforms with advanced AI to build one of the world's most comprehensive translational and preclinical immuno-oncology datasets, spanning more than 20,000 samples, to reveal</description>
</item>
<item>
<title>10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-announces-preliminary-select-fourth-quarter-and-full-year-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-announces-preliminary-select-fourth-quarter-and-full-year-2025-results</guid>
<pubDate>Sun, 11 Jan 2026 05:00:00 GMT</pubDate>
<description>PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary,</description>
</item>
<item>
<title>CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response</title>
<link>https://6ix.com/company/10x-genomics-inc/news/caredx-and-10x-genomics-launch-immunescapetm-program-multiomics-research-platform</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/caredx-and-10x-genomics-launch-immunescapetm-program-multiomics-research-platform</guid>
<pubDate>Wed, 07 Jan 2026 05:00:00 GMT</pubDate>
<description>Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using</description>
</item>
<item>
<title>10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-present-44th-annual-jp-morgan-healthcare-conference-2025-12-29</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-present-44th-annual-jp-morgan-healthcare-conference-2025-12-29</guid>
<pubDate>Mon, 29 Dec 2025 05:00:00 GMT</pubDate>
<description>PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members</description>
</item>
<item>
<title>New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium</title>
<link>https://6ix.com/company/10x-genomics-inc/news/new-astra-consortium-unites-asia-pacific-scientists-to-build-pan-cancer-spatial-atlas-powered-by-10x-genomics-xenium</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/new-astra-consortium-unites-asia-pacific-scientists-to-build-pan-cancer-spatial-atlas-powered-by-10x-genomics-xenium</guid>
<pubDate>Tue, 18 Nov 2025 14:00:00 GMT</pubDate>
<description>10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, the Garvan Institute of Medical Research in Australia and the University of Tokyo in Japan, today announced an initiative to create a comprehensive pan-cancer spatial atlas. The Asia-Pacific Spatial Translational Research Alliance (ASTRA), a consortium that fosters collaboration in spatial research across the Asia-Pacific region, will use 10x Genomics' Xenium spatial platform to map how cancer and immune cells communi</description>
</item>
<item>
<title>10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-participate-wolfe-research-healthcare-conference-2025-2025-11-11</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-participate-wolfe-research-healthcare-conference-2025-2025-11-11</guid>
<pubDate>Tue, 11 Nov 2025 05:00:00 GMT</pubDate>
<description>PLEASANTON, Calif., Nov. 11, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members</description>
</item>
<item>
<title>10x Genomics Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-reports-third-quarter-2025-financial-results-2025-11-06</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-reports-third-quarter-2025-financial-results-2025-11-06</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial</description>
</item>
<item>
<title>10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-launches-next-generation-chromium-flex-empower-scientists-massively</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-launches-next-generation-chromium-flex-empower-scientists-massively</guid>
<pubDate>Wed, 29 Oct 2025 04:00:00 GMT</pubDate>
<description>New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies PLEASANTON, Calif., Oct.</description>
</item>
<item>
<title>10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-and-anthropic-partner-make-single-cell-and-spatial-analysis-more</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-and-anthropic-partner-make-single-cell-and-spatial-analysis-more</guid>
<pubDate>Mon, 20 Oct 2025 04:00:00 GMT</pubDate>
<description>Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making</description>
</item>
<item>
<title>10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025</title>
<link>https://6ix.com/company/10x-genomics-inc/news/10x-genomics-report-third-quarter-2025-financial-results-november-6-2025-2025-10-09</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/10x-genomics-report-third-quarter-2025-financial-results-november-6-2025-2025-10-09</guid>
<pubDate>Thu, 09 Oct 2025 04:00:00 GMT</pubDate>
<description>PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report</description>
</item>
<item>
<title>CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics</title>
<link>https://6ix.com/company/10x-genomics-inc/news/cliseq-10x-genomics-and-weizmann-institute-to-investigate-single-cell-applications-in-hematology-clinical-diagnostics</link>
<guid isPermaLink="true">https://6ix.com/company/10x-genomics-inc/news/cliseq-10x-genomics-and-weizmann-institute-to-investigate-single-cell-applications-in-hematology-clinical-diagnostics</guid>
<pubDate>Tue, 09 Sep 2025 13:00:00 GMT</pubDate>
<description>CLISEQ Ltd., a translational diagnostics company spun out of Yeda, the commercial arm of the Weizmann Institute of Science, today announced a translational research collaboration with 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology and the Weizmann Institute. Together, the organizations are launching a multi-year, international clinical research study to investigate the use of peripheral single cell RNA sequencing (scRNA-seq) as a minimally invasive, clinically viab</description>
</item>
</channel>
</rss>